Literature DB >> 3411952

Impaired immune function in obstructive jaundice.

D W Vane1, P Redlich, T Weber, S Leapman, A R Siddiqui, J L Grosfeld.   

Abstract

Sepsis is a common and occasionally lethal complication of obstructive jaundice. The reasons for this increased susceptibility to infection are unknown. This study examines lymphocyte and reticuloendothelial (RES) function in animals with obstructive jaundice. Twelve New Zealand white rabbits (3-4 kg) were studied. Lymphocyte function was evaluated in six rabbits by phytohemagglutinin (PHA), concanavalin A (Con A), and pokeweed mitogen (PWM) stimulation. In six animals, hepatic RES function was assessed by calculating the phagocytic index (PI) using the disappearance of 99Tc sulfacolloid (5 mg/kg) iv. After baseline studies, the common bile duct was divided and ligated. The above studies and serum bilirubin were repeated at 3 weeks. Obstruction was then relieved by cholecystojejunostomy (CJ) and RES studies repeated monthly x 6. Preobstructive lymphocyte function showed a stimulation index ratio (log) of 0.85 +/- 0.25 for PHA, 0.75 +/- 0.3 for Con A, and 0.71 +/- 0.25 for PWM. With biliary obstruction, the values fell to -0.23 +/- 15 (P less than 0.006), -0.31 +/- 0.12 (P less than 0.006), and -0.29 (P less than 0.006), demonstrating impaired lymphocyte function. When tested lymphocytes were mixed with control pooled rabbit serum, however, no lymphocyte impairment was noted. Baseline hepatic PI was 6.02 +/- 0.18 and fell to 3.79 +/- 0.33 with obstruction (P less than .01) and remained low at (3.20 +/- 0.14) 1 month (P less than 0.01) and (3.33 +/- 0.23) at 3 months (P less than .01), after CJ but returned to normal (8.04 +/- 0.97) at 6 months.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3411952     DOI: 10.1016/0022-4804(88)90077-7

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  10 in total

1.  Altered lymphocyte subsets and natural killer cells of patients with obstructive jaundice in perioperative period.

Authors:  H Li; S T Xiong; S X Zhang; S B Liu; P N Zou; J P Xiang
Journal:  J Tongji Med Univ       Date:  1991

2.  Reticuloendothelial system blockade promotes progression from mild to severe acute pancreatitis in the opossum.

Authors:  C Schleicher; J C Baas; H Elser; N Senninger
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

3.  Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice.

Authors:  F K Welsh; C W Ramsden; K MacLennan; M B Sheridan; G R Barclay; P J Guillou; J V Reynolds
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

4.  Soluble interleukin-2 receptor and soluble CD8 in liver cirrhosis and obstructive jaundice.

Authors:  F Wagner; C Assemi; C Lersch; R Hart; M Classen
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

5.  Conclusive evidence of endotoxaemia in biliary obstruction.

Authors:  W D Clements; P Erwin; M D McCaigue; I Halliday; G R Barclay; B J Rowlands
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

6.  Role of the gut in the pathophysiology of extrahepatic biliary obstruction.

Authors:  W D Clements; R Parks; P Erwin; M I Halliday; J Barr; B J Rowlands
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

7.  Role of parenteral nutrition in preventing malnutrition and decreasing bacterial translocation to liver in obstructive jaundice.

Authors:  J H Chuang; C S Shieh; N K Chang; W J Chen; J N Lin
Journal:  World J Surg       Date:  1993 Sep-Oct       Impact factor: 3.352

8.  Alterations of tumor necrosis factor-alpha and interleukin 6 production and activity of the reticuloendothelial system in experimental obstructive jaundice in rats.

Authors:  Janusz Dawiskiba; Pawel Kornafel; Danuta Kwiatkowska; Michal Zimecki
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

9.  Biliary obstruction reduces hepatic killing and phagocytic clearance of circulating microorganisms in rats.

Authors:  Sumito Hoshino; Zhaoli Sun; Keiichiro Uchikura; Kyoji Tsugane; Eugene Ceppa; Gregory B Bulkley; Andrew S Klein
Journal:  J Gastrointest Surg       Date:  2003 May-Jun       Impact factor: 3.452

10.  Patient preparation before surgery for cholangiocarcinoma.

Authors:  E Oussoultzoglou; D Jaeck
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.